Medical marijuana developer Tilray has begun shipping to overseas patients and trial sites outside Canada after partnering with local distributors to comply with regional regulations.
Nanaimo-headquartered Tilay announced it will export medical marijuana to patients in Chile, Brazil and New Zealand this week also confirming it has started supplying product candidates to trial sites in Canada and Australia.
Tilray is familiar with the rules covering the shipment of medical marijuana in Canada. However, the differing regulations covering distribution and use of such products in the new markets required additional research, according to CEO Brendan Kennedy.
Kennedy told us: “It depends on the location. If it’s a whole plant extract, in some countries that’s easier to get through the regulatory approval process. We look at it more as a biopharmaceutical product.”
He cited New Zealand as an example, explaining that the country’s laws permit patients to access medical cannabis products with special authorization from